Description
By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually. This should not be surprising. Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing. In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC COVID-19 was stunning.
Updated for COVID-19 Impacts
In some segments, COVID-19 caused a contraction of the segment due to lockdown, closures, limited physician visits and a reduction in elective and outpatient surgery. The market is expected to resume pre-pandemic growth in all segments of the POC market. Certain segments will continue to advance significantly from 2021-2025. In 2025, the total global POC diagnostic testing market is expected to reach almost $45 billion, displaying growth of 8.9% over the forecast period 2020-2025.
- Global POC Test Market, 2020-2025 (in millions $ at manufacturer level)
- Global POC Testing Market Analysis by Product Category, 2020 (in millions $) (Self-Testing, Professional Testing, Total)
- Global POC Self-Testing Market Analysis by Product Category, 2020 (in millions$) (Glucose [includes CGM], Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine, Infectious Disease, Lipid, Total)
- Global POC Self-Testing Market Analysis by Product Category, 2020 (by %) (Infectious Disease, Urine, DOA, Coagulation, FOB, Pregnancy, Glucose)
- Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (in millions$) (Drugs of Abuse, Glucose includes HbA1c, Blood & Electrolytes, Infectious Disease, Rapid Coagulation, Fecal Occult Blood, Cardiac Markers, Lipid, Pregnancy & Fertility, Miscellaneous, Urine, Cancer Tumor Markers, Total)
- Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (by %) (Tumor Markers, Urine, Misc, Pregnancy, Lipid, Cardiac Markers, Rapid Coag, FOB, Infectious Disease, Blood/ Electrolytes, Glucose/ HbA1c, DOA)
- POC Testing by End-user, 2020 (%) (Hospitals, Others)
- Global POC Market by Technology by Sales, 2020 (%) (LFA, Biosensors, Analyzers, Strips)
- Regional Market Analysis
The POC market is also broken out by geographic region:
- Global POC Testing Analysis by Region/Country, 2020 (in millions $) (United States, Europe, Japan, ROW, Total)
- Global POC Testing Market Analysis by European Region, 2020 (in millions $) (W. Europe, E. Europe, Total)
- Europe POC Testing Percentage Participation, by Country, 2020 (Germany, UK, France, Italy, Switzerland/ Sweden, Spain, Other)
- Global POC Testing Market Analysis by Rest of World Region/Country, 2020 (in millions $) (Latin America and Mexico, China, Australia, South Korea, India, Other, Total)
- POC Blood Glucose Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Blood and Electrolytes Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Rapid Coagulation Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Rapid Cardiac Markers Testing Regional Market Analysis, 2020 (US; Europe; Japan; Latin America, India, Asia Pacific and the Middle East; RoW)
- POC Substance Abuse Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Pregnancy and Fertility Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Infectious Disease Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Lipid Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Cancer Tumor Marker Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Urine Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- POC Miscellaneous Testing Regional Market Analysis, 2020 (US, Europe, Japan, RoW)
- Segment Size and Growth
POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time more, decentralized test venues invest in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. As the menu for point-of-care testing continues to expand, the report looks in-depth at the following market segments:
- Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Diabetes Sales by Test Category, 2020-2025 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
- Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2020-2025 (in millions $ at manufacturer level)
- Global POC Continuous Glucose Self-Testing Market 2020-2025 (in millions $ at manufacturer level)
- Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2020-2025 (in millions $ at manufacturer level)
- Global POC Glucose HbA1c Professional Testing Market 2020-2025 (in millions $ at manufacturer level)
- Global POC Blood and Electrolytes Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Blood & Electrolytes Revenues by Test Category, 2020-2025 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
- Global POC Blood & Electrolytes Sales by Test Category, 2020-2025 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
- Global Rapid Coagulation Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Total Rapid Cardiac Markers Tests Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Drugs of Abuse Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Drugs of Abuse Self Testing Market, 2020-2025 (includes continuous glucose devices)
- Global POC Drugs of Abuse Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Pregnancy and Fertility Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Pregnancy and Fertility Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Pregnancy and Fertility Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Infectious Disease Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2020 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
- POC Infectious Disease Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Infectious Disease Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2018 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
- Global POC Lipid Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Lipid Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Lipid Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Cancer Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Urine Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Urine Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Urine Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global Miscellaneous POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- Global POC Miscellaneous Sales by Test Category, 2020-2025 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions) (Microbiology, TSH, Allergy, Autoimmune, Others, Total)
Consumers increasingly want to use wearable devices that not only track their health and fitness but also track self-monitored health data directly into clinical data repositories. As these wearable devices are cleared to use the same biomarkers involved in clinical laboratory tests to monitor the wearer’s health condition, then these devices will stream that data into the electronic health records (EHR) of patients with chronic diseases.
It’s not all upside – test cost will continue to weigh more heavily upon the trajectory of POC testing in many markets. In Europe, fee schedules have significantly dampened or led to the contraction of national POC markets; Switzerland is an exception through its preserved (though repeatedly contested) premiums paid to POC tests over scheduled base fees. In the United States, future changes to Medicare’s CLFS will place significant pressure on some POC tests performed in large volumes on automated systems in centralized and commercial labs. These challenges and expected forecasts given their presence are discussed in the report.
Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinic. Other terms used to describe POC testing include near-patient testing, physician’s office laboratory (POL) testing, rapid testing, patient self-testing or patient self-management, bedside testing, remote testing, or satellite testing. Some of these alternate terms actually describe segments of the POC testing market. POC tests are performed in a wide range of geographical locations such as:
- Hospital departments such as emergency departments, operating rooms, intensive care units, and others
- Physicians’ offices
- Hospital clinics
- Rural health clinics
- Student health clinics
- Retail clinics
- Pharmacies
- Homes – With testing performed by patients, visiting nurses, or other caregivers
- Nursing homes
- Prisons
POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.
The menu for point-of-care testing continues to expand. The traditional set of POC tests includes blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening.
In the past 5-10 years the following tests were added: HbA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP). The future holds even more advancement of POC tests and devices including tests for cancer, molecular assays and phone enabled tests of all kinds.
Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care; especially since new technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation, or an electronic medical record.
This report breaks out point of care testing by segment.
Among the top and/or innovative competitors discussed within Corporate Profiles are:
- 1 Step Detect Associates
- Abaxis
- Abbott Labs
- Abingdon Health
- Access Bio
- ACON Laboratories
- Aerscher Diagnostics
- Akers Biosciences
- Alfa Scientific Designs
- American Bio Medica
- Arkray
- Arlington Scientific
- Artron Laboratories
- Ascensia Diabetes Care
- Ativa Medical Corp
- Atlas Link Biotech
- Audit Diagnostics
- Augurix Diagnostic
- Autobio Diagnostics
- Axxin
- Beckman Coulter
- Becton Dickinson
- Beijing Wantai Biological Pharmaceuticals
- Bhat Bio-Tech India Private Ltd.
- Binx health
- bioLytical Laboratories
- BioMedomics
- Biomeme
- Biomerica
- And Scores of Other Companies
Table of Contents
1: Executive Summary
- Introduction
- Scope and Methodology
- Size and Growth of the Market
-
- Table 1-1: Global POC Test Market, 2020-2025 (in millions $ at manufacturer level)
- Trends Affecting the Market
- Competitive Outlook
- Market Conclusions
- Conclusion One – POC market transformed by technological progress
- Conclusion Two –POC Molecular Diagnostics continue making inroads
- Conclusion Three – Prevention and early detection at nexus of POC development
- Conclusion Four- Wearables continue to influence POC market
- Conclusion Four – Test cost will continue to be an issue worldwide
- Conclusion Five– Reimbursement and economic conditions still hot issue
- Conclusion Six – Rising demand will drive POC market in RoW markets
- Conclusion Seven – New venues – urgent & retail care
- Conclusion Eight – COVID-19’s Positive Effect
2: Introduction and Overview
- Point-of-Care Diagnostics Testing
- Industry Regulations
- POC Industry Drivers
- Medical/Healthcare related drivers
- POC Test Types
- Conditions Evaluated by POC Diagnostic Testing
3: POC Blood Glucose Tests
- Types of Blood Glucose Testing
- Fasting Blood Sugar (FBS)
- 2-Hour Postprandial Blood Sugar (PPBS)
- Glycated Hemoglobin (HbA1c)
- Products
- Blood Glucose Self-Testing
-
- Table 3-1: Selected Glucose Self-Test Meter Innovations
-
- Table 3-2: Selected Apps and Glucose Management IT
- Glycated Hemoglobin Tests
-
- Table 3-3: Selected POC HbA1c Devices
- Market Size and Growth
-
- Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Table 3-5: Global POC Diabetes Sales by Test Category, 2020-2025 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
-
- Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2020
-
- Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2020-2025 (in millions $ at manufacturer level)
-
- Table 3-7: Global POC Continuous Glucose Self-Testing Market 2020-2025 (in millions $ at manufacturer level)
- POC Glucose Professional Testing
-
- Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2020-2025 (in millions $ at manufacturer level)
-
- Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2020-2025 (in millions $ at manufacturer level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 3-2: Global POC Glucose Test Manufacturers by Percent, 2020
4: POC Blood and Electrolytes Testing Market
- Types of Blood and Electrolytes Tests
- Products
-
- Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2020
-
- Table 4-2: Selected POC Hematology Analyzer Systems, 2020
- Market Size and Growth
-
- Table 4-3: Global POC Blood and Electrolytes Testing( Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC, Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Table 4-4: Global POC Blood & Electrolytes Revenues by Test Category, 2020-2025 ($ millions)
-
- Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis 2020
- POC Blood and Electrolyte Self-Testing
-
- Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Blood and Electrolyte Professional Testing
-
- Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2020
5: POC Rapid Coagulation
- Products
-
- Table 5-1: Selected POC Coagulation Test Innovations
-
- Table 5-2: Selected Platelet Activity Test Innovations
- Market Size and Growth
-
- Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis 2020
- POC Rapid Coagulation Self-Testing
-
- Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Rapid Coagulation Professional Testing
-
- Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions$)
-
- Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2020
6: POC Rapid Cardiac Markers
- Products
- Market Size and Growth
-
- Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 6-1: POC Rapid Cardiac Markers Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
- COVID-19 Impact
- Competitive Analysis
-
- Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 6-2: Global POC Cardiac Test Manufacturers by Percent, 2020
7: POC Substance Abuse
- Overview
- Products
- Market Size and Growth
-
- Table 7-1: Global POC Drugs of Abuse Testing (mainly critical care) Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
- POC Drugs of Abuse Self-Testing
-
- Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2020-2025
- POC Drugs of Abuse Professional Testing
-
- Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2019
-
- Figure 7-2: Global POC Drug of Abuse Testing Manufacturers by Percent, 2020
8: POC Pregnancy and Fertility Testing
- Products
-
- Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
- Market Size and Growth
-
- Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
- POC Pregnancy and Fertility Self-Testing
-
- Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Pregnancy and Fertility Professional Testing
-
- Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2020
9: POC Colon Cancer Screening/Fecal Occult Blood Testing
- Products
-
- Table 9-1: Selected POC Colon Cancer Tests
- Market Size and Growth
-
- Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
- POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
-
- Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
-
- Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2020
10: POC Infectious Disease Testing
- Products
- Hospital Acquired Infections and Sepsis
-
- Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
- Market Size and Growth
-
- Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
- POC Infectious Disease Self-Testing
-
- Table 10-3: POC Infectious Disease Self-Testing(including COVID-19) Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Infectious Disease Professional Testing
-
- Table 10-4: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Infectious Disease Testing by Disease Type
-
- Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2020 (in millions $)
-
- Figure 10-2 : Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, E. coli, H. pylori, Home, Others) Percent by Disease Type 2020
-
- Figure 10-3: Global Selected POC Infectious Disease (COVID-19, Respiratory, HIV, STD, Hepatitis, C. Diff) Percent by End-user (Hospital including reference labs, physician office labs (POL) and nursing homes, pharmacy, home use and others) in 2020
- COVID-19 Impact
- Competitive Analysis
-
- Table 10-6: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 10-4: Global POC Infectious Disease Test Manufacturers by Percent, 2020
11: POC Lipid Testing
- Products
- Market Size and Growth
-
- Table 11-1: Global POC Lipid Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
-
- Table 11-2: POC Lipid Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Lipid Professional Testing
-
- Table 11-3: POC Lipid Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 11-2: Global POC Lipid Testing Manufacturers by Percent, 2020
12: POC Cancer Tumor Marker Testing
- Products
-
- Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
- Market Size and Growth
-
- Table 12-2: Global POC Cancer Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
- COVID-19 Impact
- Competitive Analysis
-
- Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 12-2: Global POC Cancer Testing Manufacturers by Percent, 2020
13: POC Urine Testing
- Products
- Market Size and Growth
-
- Table 13-1: Global POC Urine Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
-
- Table 13-2: POC Urine Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- POC Urine Test Professional Testing
-
- Table 13-3: POC Urine Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
- COVID-19 Impact
- Competitive Analysis
-
- Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 13-2: Global POC Urine Strip Testing Manufacturers by Percent, 2020
14: Miscellaneous POC Testing
- Microbiology
- TSH
- Allergy
- Autoimmune
- Others
- Market Size and Growth
-
- Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Table 14-2: Global POC Miscellaneous Sales by Test Category, 2020-2025 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions)
-
- Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
- COVID-19 Impact
15: Issues and Trends
- Overview
- Wearables
-
- Table 15-1: Selected Wearable Devices
- Mobile Healthcare Technologies
- Telehealth
- Patient-centered Healthcare
- Breath Test Advances
-
- Table 15-2: Selected Disease Markers in Exhaled Breath
- Regulatory Hurdles
- Reimbursement Challenges
- PAMA
- Competition
- POC and Molecular Diagnostics
-
- Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
- Funding Developments in POC
- POC and Biosensors and Microfluidics
-
- Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2020
-
- Table 15-5: Selected Biochip and Biosensor Players, 2020
- China as a POC Market
- Emerging POC Technologies
- POC Connectivity
- Multiplexed POC Testing
-
- Figure 15-6: Multiplexed POC Testing Schematic
- The Emergence of Non-invasive Technologies
- POC and Antibiotic Resistance Concern
16: Total Global POC Testing Market and Competitor Analysis
- Market Overview
-
- Table 16-1: Global POC Test Market, 2020-2025 (in millions $ at manufacturer level)
- Market Analysis by Product Categories
-
- Table 16-2: Global POC Testing Market Analysis by Product Category, 2020 (in millions $)
- Market Analysis by Subcategory
-
- Table 16-3: Global POC Self-Testing Market Analysis by Product Category, 2020 (in millions$)
-
- Figure 16-1: Global POC Self-Testing Market Analysis by Product Category, 2020 (by %)
-
- Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (in millions$)
-
- Figure 16-2 : Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (by %)
-
- Figure 16-3: POC Testing by End-user, 2020
- Market by Device Technology
-
- Figure 16-4: Global POC Market by Technology by Sales 2020
- Market Analysis by Country
-
- Table 16-5: US POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Table 16-6: Europe POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Table 16-7: Global POC Testing Market Analysis by European Region, 2020 (in millions $)
-
- Figure 16-5: Europe POC Testing Percentage Participation, by Country, 2020
-
- Table 16-8: Japan POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
-
- Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country, 2020 (in millions $)
-
- Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country, 2020
-
- Table 16-10: Global POC Testing Analysis by Region/Country, 2020 (in millions $)
-
- Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country, 2020
- COVID-19 Impact
- Competitive Analysis
-
- Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
-
- Figure 16-8: Global POC Testing Market Share by Leading Suppliers, 2020
17: Corporate Profiles
- Overview
- 1 Step Detect Associates, LLC
-
- Table 17-1: 1-Step Detect Associates Corporate Summary
- Abaxis, Inc.
-
- Table 17-2: Abaxis Corporate Summary
- Abbott Laboratories
-
- Table 17-3: Abbott Corporate Summary
-
- Table 17-4: Abbott Revenues 2018-2020 (in millions $)
- Abingdon Health, Ltd.
-
- Table 17-5: Abingdon Health Corporate Summary
- AccessBio, Inc.
-
- Table 17-6: AccessBio Corporate Summary
- AccuBioTech Co, Ltd.
-
- Table 17-7: AccuBioTech Corporate Summary
- ACON Laboratories, Inc
-
- Table 17-8: ACON Laboratories Corporate Summary
- Aerscher Diagnostics, LLC
-
- Table 17-9: Aerscher Diagnostics Corporate Summary
- Akers Biosciences, Inc.
-
- Table 17-10: Akers Biosciences Corporate Summary
- Alfa Scientific Designs, Inc
-
- Table 17-11: Alfa Scientific Corporate Summary
- American Bio Medica Corporation
-
- Table 17-12: American Bio Medica Corporate Summary
-
- Table 17-13: American Bio Medica Corporation Revenue (2017-2020) ($ millions)
- Arlington Scientific, Inc.
-
- Table 17-14: Arlington Scientific Corporate Summary
- Arkray, Inc.
-
- Table 17-15: Arkray Corporate Summary
- Artron Laboratories, Inc
-
- Table 17-16: Artron Laboratories Corporate Summary
- Ascensia Diabetes Care Holdings AG
-
- Table 17-17: Ascensia Diabetes Care Corporate Summary
- Atlas Link Biotech Co., Ltd
-
- Table 17-18: Atlas Link Biotech Corporate Summary
- Ativa Medical Corporation
-
- Table 17-19: Ativa Medical Corporate Summary
- Audit Diagnostics
-
- Table 17-20: Audit Diagnostics Corporate Summary
- Autobio Diagnostics Co., Ltd
-
- Table 17-21: Autobio Diagnostics Corporate Summary
- Augurix Diagnostic
-
- Table 17-22: Augurix Diagnostic Corporate Summary
- Axxin
-
- Table 17-23: Axxin Corporate Summary
- Beckman Coulter, Inc
-
- Table 17-24: Beckman Coulter Corporate Summary
-
- Table 17-25: Beckman Coulter Revenue (2017-2020) ($ millions)
- Becton Dickinson (BD)
-
- Table 17-26: BD Corporate Summary
-
- Table 17-27: BD Corporation Revenue (2017-2020) ($ millions)
- Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-
- Table 17-28: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
- Bhat Bio-Tech India Private Ltd. (BBI)
-
- Table 17-29: Bhat Bio-Tech India Private Corporate Summary
- binx health
-
- Table 17-30: binx health Corporate Summary
- bioLytical Laboratories
-
- Table 17-31: bioLytical Laboratories Corporate Summary
- Biomerica, Inc.
-
- Table 17-32: Biomerica Corporate Summary
-
- Table 17-33: Biomerica Corporation Revenue (2017-2020) ($ millions)
- BioMedomics, Inc
-
- Table 17-34: BioMedomics Corporate Summary
- Biomeme, Inc
-
- Table 17-35: Biomeme Corporate Summary
- bioMerieux SA
-
- Table 17-36: bioMerieux SA Corporate Summary
-
- Table 17-37: bioMerieux Revenues (2017-2020) ($ millions)
- Biophor Diagnostics, Inc
-
- Table 17-38: Biophor Diagnostics Corporate Summary
- Bio-Rad Laboratories Inc.
-
- Table 17-39: Bio-Rad Labs Corporate Summary
-
- Table 17-40: Bio-Rad Corporation Revenue (2017-2020) ($ millions)
- Biotron Diagnostics, Inc.
-
- Table 17-41: Biotron Diagnostics Corporate Summary
- Biosensia Ltd.
-
- Table 17-42: Biosensia Corporate Summary
- Boditech Med Inc
-
- Table 17-43: Boditech Med Corporate Summary
- Boson Biotech Co. Ltd
-
- Table 17-44: Boson Biotech Corporate Summary
- BNTX Inc.
-
- Table 17-45: BNTX Corporate Summary
- Calypte Biomedical Corporation
-
- Table 17-46: Calypte Biomedical Corporate Summary
- Cepheid, Inc
-
- Table 17-47: Cephid Corporate Summary
-
- Table 17-48: Cepheid Revenues (2017-2020) ($ millions)
- Chembio Diagnostics, Inc.
-
- Table 17-49: Chembio Diagnostic Corporate Summary
-
- Table 17-50: Chembio Diagnostics Revenues (2017-2020) ($ millions)
- Church & Dwight Co. Inc
-
- Table 17-51: Church & Dwight Corporate Summary
-
- Table 17-52: Church and Dwight Revenues (2017-2020) ($ millions)
- Clarity Diagnostics, LLC
-
- Table 17-53: Clarity Diagnostics Corporate Summary
- Confirm Biosciences
-
- Table 17-54: Confirm Biosciences Corporate Summary
- CTK Biotech, Inc.
-
- Table 17-55: CTK Biotech Corporate Summary
- Danaher Corporation
-
- Table 17-56: Danaher Corporation Summary
-
- Table 17-57: Danaher Revenues (2017-2020) ($ millions)
- Dexcom, Inc
-
- Table 17-58: Dexcom Corporate Summary
-
- Table 17-59: Dexcom Revenues (2017-2020) ($ millions)
- DIALAB GmbH
-
- Table 17-60: DIALAB Corporate Summary
- DiaSys Diagnostic Systems GmbH
-
- Table 17-61: DiaSys Diagnostic Systems Corporate Summary
- DxGen Corp.
-
- Table 17-62: DxGen Corporate Summary
- Diazyme Laboratories, Inc.
-
- Table 17-63: Diazyme Laboratories Corporate Summary
- DNA Electronics Ltd. (DNAe)
-
- Table 17-64: DNA Electronics Corporate Summary
- Dragerwerk AG & Co. KGaA
-
- Table 17-65: Dragerwerk Corporate Summary
-
- Table 17-66: Dragerwerk Revenues (2017-2020) ($ millions)
- Dr. Fooke-Achterrath Laboratorien GmbH
-
- Table 17-67: Dr. Fooke-Achterrath Laboratorien Corporate Summary
- DRG International, Inc.
-
- Table 17-68: DRG International Corporate Summary
- Eiken Chemical Co Ltd.
-
- Table 17-69: Eiken Chemical Corporate Summary
-
- Table 17-70: Eiken Chemical Revenues (2017-2020) ($ millions)
- EKF Diagnostics Holdings plc
-
- Table 17-71: EKF Diagnostics Corporate Summary
-
- Table 17-72: EKF Diagnostics Revenues (2017-2020) ($ millions)
- ELITechGroup, Inc.
-
- Table 17-73: ELITechGroup Corporate Summary
- Enterix, Inc. (Clinical Genomics)
-
- Table 17-74: Enterix Corporate Summary
- Eurobio Scientific
-
- Table 17-75: Eurobio Scientific Corporate Summary
- Eurolyser Diagnostica GmbH
-
- Table 17-76: Eurolyser Diagnostica Corporate Summary
- Everlywell
-
- Table 17-77: Everlywell Corporate Summary
- Exact Sciences
-
- Table 17-78: Exact Sciences Corporate Summary
-
- Table 17-79: Exact Sciences Revenues (2017-2020) ($ millions)
- EY Laboratories
-
- Table 17-80: EY Laboratories Corporate Summary
- Fio Corporation
-
- Table 17-81: Fio Corporate Summary
- First Check Diagnostics LLC
-
- Table 17-82: First Check Diagnostics Corporate Summary
- GenBio
-
- Table 17-83: GenBio Corporate Summary
- Genedrive plc
-
- Table 17-84: Genedrive Corporate Summary
-
- Table 17-85: Genedrive Revenues (2017-2020) ($ millions)
- GenePOC
-
- Table 17-86: GenePOC Corporate Summary
- GeTein BioMedical, Inc.
-
- Table 17-87: GeTein Corporate Summary
- GlysBy snc
-
- Table 17-88: GlysBy Corporate Summary
- Helena Laboratories
-
- Table 17-89: Helena Laboratories Corporate Summary
- Hemosure, Inc.
-
- Table 17-90: Hemosure Corporate Summary
- HORIBA, Ltd.
-
- Table 17-91: HORBIA Corporate Summary
-
- Table 17-92: HORIBA Revenues (2017-2020) ($ millions)
- Immunosciences Lab, Inc.
-
- Table 17-93: Immunosciences Lab Corporate Summary
- Immunostics, Inc
-
- Table 17-94: Immunostics Corporate Summary
- InSilixa, Inc
-
- Table 17-95: InSilixa Corporate Summary
- Instrumentation Laboratory
-
- Table 17-96: Instrumentation Laboratory Corporate Summary
- JAL Innovation PTE LTD
-
- Table 17-97: JAL Innovation Corporate Summary
- Jant Pharmacal Corporation
-
- Table 17-98: Jant Pharmacal Corporate Summary
- J. Mitra & Co Pvt. Ltd
-
- Table 17-99: J Mitra Corporate Summary
- LamdaGen Corporation
-
- Table 17-100: LamdaGen Corporate Summary
- LifeScan, Inc
-
- Table 17-101: LifeScan Corporate Summary
- LifeSign, LLC
-
- Table 17-102: LifeSign Corporate Summary
- Loop Medical
-
- Table 17-103: Loop Medical Corporate Summary
- Macherey-Nagel GmbH & Co. KG
-
- Table 17-104: Macherey-Nagel Corporate Summary
- Magnasense Technologies
-
- Table 17-105: Magnasense Technologies Corporate Summary
- MBio Diagnostics, Inc (LightDeck Diagnostics)
-
- Table 17-106: MBio Diagnostics Corporate Summary
- Medix Biochemica
-
- Table 17-107: Medix Biochemica Corporate Summary
- MedMira, Inc
-
- Table 17-108: MedMira Corporate Summary
-
- Table 17-109: MedMira Revenues (2017-2020) ($ thousands)
- Medtronic, Inc.
-
- Table 17-110: Medtronic Corporate Summary
-
- Table 17-111: Medtronic Revenues (2017-2020) ($ millions)
- A. Menarini Diagnostics srl.
-
- Table 17-112: Menarini Diagnostics Corporate Summary
- Meridian Bioscience, Inc
-
- Table 17-113: Meridian Bioscience Corporate Summary
-
- Table 17-114: Meridian Bioscience (2017-2020) ($ millions)
- MiCo BioMed USA
-
- Table 17-115: MiCo BioMed Summary
- Nano-Ditech Corporation
-
- Table 17-116: Nano-Ditech Corporate Summary
- NG Biotech
-
- Table 17-117: NG Biotech Corporate Summary
- Noble Medical, Inc
-
- Table 17-118: Noble Medical Corporate Summary
- Nova Biomedical Corp.
-
- Table 17-119: Nova Biomedical Corporate Summary
- NuGenerex Diagnostics
-
- Table 17-120: NuGenerex Diagnostics Corporate Summary
- Oasis Diagnostics Corporation
-
- Table 17-121: Oasis Diagnostics Corporate Summary
- Operon S.A.
-
- Table 17-122: Operon Corporate Summary
- OPKO Health, Inc
-
- Table 17-123: OPKO Health Corporate Summary
-
- Table 17-124: OPKO Health Revenues (2017-2020) ($ millions)
- OPTI Medical Systems, Inc
-
- Table 17-125: OPTI Medical Corporate Summary
- OraSure Technologies, Inc.
-
- Table 17-126: OraSure Technologies Corporate Summary
-
- Table 17-127: Selected OraSure Products
-
- Table 17-128: OraSure Revenues (2017-2020) ($ millions)
- Polymed Therapeutics Inc.
-
- Table 17-129: Polymed Therapeutics Corporate Summary
- Polymedco, Inc
-
- Table 17-130: Polymedco Corporate Summary
- Polymer Technologies, Inc (PTS Diagnostics)
-
- Table 17-131: Polymer Technologies Corporate Summary
- Preventis GmbH
-
- Table 17-132: Preventis Corporate Summary
- Princeton Biomeditech Corporation
-
- Table 17-133: Princeton Biomeditech Corporate Summary
- QuantuMDx Group Limited
-
- Table 17-134: QuantuMDx Group Corporate Summary
- Quidel Corporation
-
- Table 17-135: Quidel Corporate Summary
-
- Table 17-136: Quidel Revenues (2017-2020) ($ millions)
- Radiometer Medical A/S
-
- Table 17-137: Radiometer Medical Corporate Summary
-
- Table 17-138: Radiometer (2017-2020) ($ millions)
- Randox Laboratories Limited
-
- Table 17-139: Randox Labs Corporate Summary
- RENESA UG
-
- Table 17-140: RENESA UG Corporate Summary
- Response Biomedical Corp
-
- Table 17-141: Response Biomedical Corporate Summary
- Reszon Diagnostics International Sdn. Bhd.
-
- Table 17-142: Reszon Diagnostics Corporate Summary
- Rheonix, Inc
-
- Table 17-143: Rheonix Corporate Summary
- Roche Diagnostic Corporation
-
- Table 17-144: Roche Diagnostic Corporate Summary
-
- Table 17-145: Roche POC Marketed Products
-
- Table 17-146: Roche Diagnostics (2017-2020) ($ millions)
- Savyon Diagnostics
-
- Table 17-147: Savyon Diagnostics Corporate Summary
- Sekisui Diagnostics LLC
-
- Table 17-148: Sekisui Diagnostics Corporate Summary
- Siemens Healthineers GmbH
-
- Table 17-149: Siemens Healthineers Corporate Summary
-
- Table 17-150: Siemens Healthineers (2017-2020) ($ millions)
- Spectral Medical, Inc
-
- Table 17-151: Spectral Medical Summary
- Sysmex Corporation
-
- Table 17-152: Sysmex Corporate Summary
-
- Table 17-153: Sysmex (2017-2020) ($ millions)
- TECHLAB, Inc.
-
- Table 17-154: TECHLAB Corporate Summary
- Teco Diagnostics
-
- Table 17-155: Teco Diagnostics Corporate Summary
- Trinity Biotech PLC
-
- Table 17-156: Trinity Biotech Corporate Summary
-
- Table 17-157: Trinity Biotech Revenue (2017-2020) ($ millions)
- Trividia Health
-
- Table 17-158: Trividia Health Corporate Summary
- Tulip Diagnostics Ltd
-
- Table 17-159: Tulip Diagnostics Corporate Summary
- Product
- VedaLab
-
- Table 17-160: VedaLab Corporate Summary
- Veredus Laboratories PTE Ltd
-
- Table 17-161: Veredus Labs Corporate Summary
- Vircell
-
- Table 17-162: Vircell Corporate Summary
- WAMA Diagnostica
-
- Table 17-163: WAMA Diagnostica Corporate Summary
- Wave 80 Biosciences
-
- Table 17-164: Wave 80 Biosciences Corporate Summary
- Werfen
-
- Table 17-165: Werfen Corporate Summary
-
- Table 17-166: Werfen (2017-2020) ($ millions)
